Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linhui Wang

Showing results (191-200 of 223) with videos related to

Pageof 23
Sort By:
World Journal of Urology|March 13, 2024
Robot-assisted single-port retroperitoneal partial nephrectomy with a novel purpose-built single-port robotic system with deformable surgical instrumentsChao Zhang, Zheng Wang, Taile Jing, et al.
Asian Journal of Urology|January 24, 2020
Natural orifice transluminal endoscopic surgery in urology: The Chinese experienceXiaofeng Zou, Guoxi Zhang, Tianpeng Xie, et al.
European Urology Open Science|August 8, 2024
Robot-assisted Single-port Radical Prostatectomy with the SHURUI SP and da Vinci SP Platforms: Comparison of the Technology, Intraoperative Performance, and OutcomesZhenjie Wu, Zheng Wang, Marcio Covas Moschovas, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2019
Mutational inactivation of mTORC1 repressor gene <i>DEPDC5</i> in human gastrointestinal stromal tumorsYuzhi Pang, Feifei Xie, Hui Cao, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2024
Proteomic and phosphoproteomic landscape of localized prostate cancer unveils distinct molecular subtypes and insights into precision therapeuticsZengming Wang, Haolan Yu, Wei Bao, et al.
European Urology|February 1, 2022
Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysisZhenjie Wu, Qi Chen, Le Qu, et al.
Cell Metabolism|September 11, 2021
The thermogenic activity of adjacent adipocytes fuels the progression of ccRCC and compromises anti-tumor therapeutic efficacyGang Wei, Honglin Sun, Kai Dong, et al.
International Urology and Nephrology|June 21, 2025
Robotic partial nephrectomy to treat large (T2) cystic renal cell carcinoma: a multi-institutional analysis (ROSULA Collaborative Group)Lin Zhao, Xiaolei Shi, Fei Guo, et al.
Science Advances|April 9, 2025
Intratumoral mycobiome heterogeneity influences the tumor microenvironment and immunotherapy outcomes in renal cell carcinomaWeiming Mou, Zhixing Deng, Lingxuan Zhu, et al.
Science Advances|February 11, 2021
Genome-wide CRISPR-Cas9 screen identified KLF11 as a druggable suppressor for sarcoma cancer stem cellsYicun Wang, Jinhui Wu, Hui Chen, et al.
Pageof 23

Showing results (191-200 of 223) with videos related to

Sort By:
Pageof 23
World Journal of Urology|March 13, 2024
Robot-assisted single-port retroperitoneal partial nephrectomy with a novel purpose-built single-port robotic system with deformable surgical instrumentsChao Zhang, Zheng Wang, Taile Jing, et al.
Asian Journal of Urology|January 24, 2020
Natural orifice transluminal endoscopic surgery in urology: The Chinese experienceXiaofeng Zou, Guoxi Zhang, Tianpeng Xie, et al.
European Urology Open Science|August 8, 2024
Robot-assisted Single-port Radical Prostatectomy with the SHURUI SP and da Vinci SP Platforms: Comparison of the Technology, Intraoperative Performance, and OutcomesZhenjie Wu, Zheng Wang, Marcio Covas Moschovas, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2019
Mutational inactivation of mTORC1 repressor gene <i>DEPDC5</i> in human gastrointestinal stromal tumorsYuzhi Pang, Feifei Xie, Hui Cao, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2024
Proteomic and phosphoproteomic landscape of localized prostate cancer unveils distinct molecular subtypes and insights into precision therapeuticsZengming Wang, Haolan Yu, Wei Bao, et al.
European Urology|February 1, 2022
Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysisZhenjie Wu, Qi Chen, Le Qu, et al.
Cell Metabolism|September 11, 2021
The thermogenic activity of adjacent adipocytes fuels the progression of ccRCC and compromises anti-tumor therapeutic efficacyGang Wei, Honglin Sun, Kai Dong, et al.
International Urology and Nephrology|June 21, 2025
Robotic partial nephrectomy to treat large (T2) cystic renal cell carcinoma: a multi-institutional analysis (ROSULA Collaborative Group)Lin Zhao, Xiaolei Shi, Fei Guo, et al.
Science Advances|April 9, 2025
Intratumoral mycobiome heterogeneity influences the tumor microenvironment and immunotherapy outcomes in renal cell carcinomaWeiming Mou, Zhixing Deng, Lingxuan Zhu, et al.
Science Advances|February 11, 2021
Genome-wide CRISPR-Cas9 screen identified KLF11 as a druggable suppressor for sarcoma cancer stem cellsYicun Wang, Jinhui Wu, Hui Chen, et al.
Pageof 23